2024 Succeeding in the Pharmaceutical Market: Supplier Strategies and Capabilities
Will the industry consolidate, decentralize, or undergo a bimodal transformation?How will the current trends affect the major market segments? Which companies will enter the market and which will not survive? The companies analyzed in this report include:
Abbvie
AstraZeneca
Bristol Myers Squibb
GSK
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Sanofi
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs.
The analysis includes:Latest organizational and management developmentsAcquisitions and divestitures Marketing tactics Financial results Strengths and weaknesses Strategic directions In the dynamic and fragmented Pharmaceutical industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.
The report’s objectives include:To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.To complement organizations’ internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
Abbvie
AstraZeneca
Bristol Myers Squibb
GSK
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Sanofi
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs.
The analysis includes:Latest organizational and management developments
The report’s objectives include:To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
More Publications
2020 Molecular Blood Banking and NAT Screening Market: Supplier Shares by Country, Instrumentation Review, Strategic Profiles of Leading Competitors
US$ 3,850.00
January 2020
111 pages
2019 C4 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
US$ 950.00
July 2019
-
2020-2025 Global Clinical Chemistry Database for the US, Europe, Japan: Analyzers and Reagents for 100 Tests, Supplier Shares, Volume and Sales Segment Forecasts
US$ 17,500.00
November 2020
-